Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Capital Expenditures (2017 - 2026)

Sensus Healthcare has reported Capital Expenditures over the past 9 years, most recently at $158000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 153.2% year-over-year to $158000.0; the TTM value through Dec 2025 reached $196000.0, down 28.99%, while the annual FY2025 figure was $196000.0, 28.99% down from the prior year.
  • Capital Expenditures for Q4 2025 was $158000.0 at Sensus Healthcare, up from $4000.0 in the prior quarter.
  • Over five years, Capital Expenditures peaked at $337000.0 in Q3 2024 and troughed at -$297000.0 in Q4 2024.
  • A 5-year average of $52000.0 and a median of $29000.0 in 2023 define the central range for Capital Expenditures.
  • Biggest five-year swings in Capital Expenditures: skyrocketed 2963.64% in 2024 and later tumbled 98.81% in 2025.
  • Year by year, Capital Expenditures stood at $38000.0 in 2021, then tumbled by 73.68% to $10000.0 in 2022, then rose by 10.0% to $11000.0 in 2023, then tumbled by 2800.0% to -$297000.0 in 2024, then soared by 153.2% to $158000.0 in 2025.
  • Business Quant data shows Capital Expenditures for SRTS at $158000.0 in Q4 2025, $4000.0 in Q3 2025, and $27000.0 in Q2 2025.